INTRODUCTION
The family of A kinase-anchoring proteins (AKAPs) has emerged as a convergent point of diverse signals to achieve spatiotemporal specificity. Besides the extensive studies on its regulation of ion-channel activity and trafficking, AKAP79/150 (human AKAP79/rodent AKAP150) has been shown to be intimately involved in synaptic plasticity, and learning and memory (Horne and Dell'Acqua, 2007; Lu et al., 2007; Tavalin et al., 2002; Tunquist et al., 2008; Weisenhaus et al., 2010) . A direct role of AKAP79/150 in gene transcription has been implicated, highlighting nuclear or plasma membrane complexes it organizes with signaling components of cAMP/CREB or calcineurin (CaN)/nuclear factor of activated T cell (NFAT) signaling pathways (Oliveria et al., 2007; Sample et al., 2012) . NFAT transcription factors are activated by intracellular Ca 2+ (Ca 2+ i ) signals in concert with CaN and play critical roles in neural development, axon growth, and b-amyloid neurotoxicity (Graef et al., 1999 (Graef et al., , 2003 Hudry et al., 2012; Wu et al., 2012) . AKAP79/150 has been suggested to play a role in the regulation of neuronal excitability and susceptibility to seizures (Tunquist et al., 2008) . Recent structural and biochemical studies further reveal the stoichiometry of the core AKAP79-dimer/PKA/CaN complex and suggest the mechanism of CaN activation by Ca 2+ /CaM binding to AKAP79 and NFAT activation by dissociation of CaN from the AKAP79 complex (Gold et al., 2011; Li et al., 2012) . However, few genes in the nervous system presumed to be regulated by NFAT have actually been identified.
Voltage-gated M-type (KCNQ, Kv7) K + channels, expressed in a wide variety of neurons, play critical roles in modulation of neuronal excitability and action potential firing (Delmas and Brown, 2005) . KCNQ2 and KCNQ3 underlie most neuronal M currents which are partly regulated by AKAP79/150-mediated PKC phosphorylation (Hoshi et al., 2003 (Hoshi et al., , 2005 Zhang et al., 2011 ). Yet, despite the importance of M channels in control over neuronal excitability, very little is known about their transcriptional regulation, which would have profound implications for nervous function. Mechanisms of transcriptional upregulation have not been described but rather downregulation by the transcriptional repressor, REST, in sensory neurons (Mucha et al., 2010; Rose et al., 2011) . In this paper, we discover a distinct role of AKAP79/150 in modulation of M currents, by mediating activity-dependent regulation of KCNQ2 and KCNQ3-channel gene transcription. We examined the hypothesis that neuronal activity, which is regulated by M current, induces NFAT-mediated transcriptional upregulation of the very KCNQ channels that can dampen excitability. Increased expression of KCNQ2/3 channels operates in a negative feedback manner to suppress hyperexcitability of neurons. We show that AKAP79/150 orchestrates a signaling complex that includes CaN and L-type (Ca V 1.3) Ca 2+ channels, the activity ''reporter'' of the neurons. This signaling pathway may potentially serve throughout the nervous system to limit overexcitability, which underlies myriad disorders such as chronic pains, epilepsies, and cardiovascular dysfunction.
RESULTS

Neuronal Stimulation Induces Increased M-Channel Expression
We first examined whether M-channel transcription and expression in sympathetic neurons of rodent superior cervical ganglion (SCG) are regulated by neuronal stimulation, using both quantitative real-time PCR (qPCR) and patch-clamp electrophysiology. As previously reported by Hadley et al. (2003) , strong KCNQ2 and KCNQ3, but little KCNQ1, transcripts express in juvenile rat SCG neurons ( Figure 1A ). The relative expression levels for KCNQ1-KCNQ3 transcripts, normalized by expression level of the housekeeping b-actin RNA, were (0.002 ± 0.001) 3 10 À3 , (1.11 ± 0.03) 3 10 À3 , and (0.74 ± 0.18) 3 10 À3 (n = 3), respectively. We then compared the effect of neuronal stimulation on the levels of KCNQ2 and KCNQ3 transcripts. Neuronal activity was mimicked by two methods: (1) depolarization by perfusion (10-15 min) of a high-K + solution (50 mM); or (2) application of acetylcholine (ACh, 1 mM), which is a more physiological way to depolarize and excite the neurons via stimulation of nicotinic ACh receptors. Perfusion by regular Ringer's solution served as a negative control. Total RNA was extracted after 7 hr and qPCR performed ( Figure 1B ). We detected significant increases in both KCNQ2 and KCNQ3 mRNA in neurons stimulated by 50 K + or ACh ( Figure 1C ). For KCNQ2, the relative expression levels in neurons treated with high K + or ACh were 2.05 ± 0.44 (n = 4; p < 0.05), and 1.80 ± 0.19 (n = 4; p < 0.05), respectively. For KCNQ3 transcripts, they were 1.76 ± 0.51 (n = 4; p < 0.05) and 1.56 ± 0.22 (n = 4; p < 0.05), respectively. M-current (I M ) amplitudes in SCG neurons were then quantified to assay expression of functional M channels. As in the previous qPCR experiments, neurons were perfused by 50 K + , ACh, or regular Ringer's solution for 15 min, and after 1, 48, 60, or 72 hr studied under perforated-patch voltage clamp. We did not observe a significant difference of I M amplitudes between neurons treated with regular Ringer's and 50 K + solutions 1 hr after stimulation, but we observed significant upregulation of I M amplitudes in neurons treated with 50 K + solution after 48, 60, or 72 hr, indicating that altered expression of M channels is involved. We thus decided to measure I M amplitudes 48-60 hr after stimulation in this paper, and examples of I M traces recorded from such neurons before and after application of the M-channel-specific blocker, XE991 (Zaczek et al., 1998) , are shown in Figure 1D . I M amplitudes were normalized to membrane capacitance and the current density used to indicate expression of functional M channels. In neurons treated with 50 K + or ACh-containing solutions, I M amplitudes were significantly augmented ( Figure 1E ). For neurons treated with regular Ringer's or 50 K + -containing solutions, the current densities were 0.78 ± 0.10 pA/pF (n = 14) and 1.24 ± 0.12 pA/pF (n = 14; p < 0.01), respectively. For neurons treated with regular Ringer's or ACh, the current densities were 0.81 ± 0.06 pA/pF (n = 12) and 1.25 ± 0.15 pA/pF (n = 14; p < 0.01), respectively.
The Activity-Dependent Regulation of M-Channel Expression Is Mediated by NFAT NFAT signaling is critical to neural development and axon growth (Graef et al., 2003) , as well as transcriptional regulation of several voltage-dependent K + channels, e.g., upregulation of K V 4.2 mRNA in cardiomyocytes (Gong et al., 2006) and downregulation of K V 2.1 mRNA in arterial smooth muscle (Amberg et al., 2004) . In the rat SCG neurons that we study here, NFATc1-NFATc4 has been shown to be expressed and, when activated, to translocate from cytoplasm to nucleus by electrical stimulation and kinase inhibitors (Herná ndez-Ochoa et al., 2007) . We performed qPCR on SCG neurons and detected transcripts for NFATc1-NFATc4 isoforms (data not shown). We then asked which transcription factors mediate the upregulation of M-channel expression seen here, hypothesizing activity-dependent production of Ca 2+ /CaN and NFAT activation to be crucial. To obtain evidence for elevated M-channel expression by NFAT, we monitored I M amplitudes after direct activation or suppression of CaN/NFAT signaling. First, we tested the effect of exogenous expression of a constitutively active NFAT mutant (CA-NFAT) that does not require CaN to be activated. SCG neurons, transfected with either EGFP-tagged CA-NFAT or only EGFP, were treated with regular Ringer's or 50 K + solutions, and I M was recorded after 48-60 hr. Successfully transfected neurons were identified by EGFP fluorescence (Figure 2A ). In CA-NFAT-expressing neurons treated with regular Ringer's solution, the tonic amplitude of I M was much larger (1.44 ± 0.22 pA/ pF, n = 10) than in control neurons (0.85 ± 0.09 pA/pF, n = 12), with current augmentation similar to that normally seen after high-K + stimulation (1.55 ± 0.18 pA/pF, n = 14; p < 0.01). Furthermore, high-K + treatment did not further increase I M amplitudes in CA-NFAT-expressing neurons (1.63 ± 0.17 pA/pF, n = 13) ( Figures 2A and 2B ), suggesting that high-K + treatment induces M-channel expression through activation of NFATs. Our second test was to knock down endogenous NFAT activity using shRNA for NFATc1 or NFATc2. We transfected EGFP-tagged shRNA for NFATc1, NFATc2, or scrambled shRNA as a control, into SCG neurons from wild-type (WT) mice, which also showed increased I M when treated with high-K + solution (1.28 ± 0.08 pA/pF, n = 13), compared with regular Ringer's (0.87 ± 0.05 pA/pF, n = 18) ( Figures 2C and 2D ). In NFATc1-shRNA or NFATc2-shRNA-expressing neurons, the increase in I M amplitude by 50 K + was largely blunted (0.93 ± 0.10 pA/pF, n = 13, and 1.03 ± 0.06 pA/ pF, n = 13, respectively) compared to neurons transfected with scrambled shRNA (1.39 ± 0.11 pA/pF, n = 18; p < 0.01) ( Figures  2C and 2D ). These data suggest that activation of NFAT transcription factors underlies the increased expression of M current by neuronal stimulation. The shRNA data also suggest that both NFATc1 and NFATc2 activity are required. Figure 3A . At rest, EGFP-NFATc1 localized mostly to the cytoplasm. A rapid increase of [Ca 2+ ] i throughout the soma was observed after neurons were stimulated by depolarization with 50 K + . The nuclear translocation of EGFP-NFATc1 from the cytoplasm commenced much more slowly, was essentially complete within $20 min, and lasted for at least 30 min (Figure 3A ; n = 11) (see Movie S1, available online). We performed similar simultaneous imaging of NFAT and [Ca 2+ ] i on neurons transfected with EGFP-tagged NFATc2-NFATc4. We observed similar, rapid [Ca 2+ ] i elevations in neurons transfected with EGFP-NFATc2-NFATc4 but only observed NFAT nuclear translocation for n = 20, 16, 22) .
In hippocampal neurons, L-type Ca 2+ channels have been suggested as pivotal for CaN/NFAT signaling (Graef et al., 1999; Oliveria et al., 2007) ; however, the L-type current is only <5% of total I Ca in rat SCG neurons (Plummer et al., 1989 ). Thus, we tested whether including the L-channel agonist, FPL-64716 (Baxter et al., 1993) ] i elevations and EGFP-NFATc1 nuclear translocation when neurons were excited using ACh (n = 10; Figures 3D and 3E ; for the statistics, see Supplemental Information). Thus, in sympathetic neurons, neuronal activity induces nuclear translocation of NFATc1 and NFATc2 that is coupled with strong increases in [Ca 2+ ] i . Because the responses of exogenously expressed signaling proteins may differ from endogenous ones, we also performed experiments to test the nuclear translocation of endogenous NFAT by immunostaining/confocal microscopy. We again chose to examine the nuclear translocation of NFATc1. Cultured rat SCG neurons were treated with 50 K + or ACh for 15 min, fixed, and immunostained by antibodies against NFATc1 before stimulation (not stimulated, ''NS'' in the figures) or at 15-120 min after stimulation. Tyrosine hydroxylase (TH) was used as a sympathetic neuronal marker, and DAPI was used to stain nuclei. The subcellular distribution of endogenous NFAT was visualized by confocal microscopy, and nuclear staining levels were calculated as the ratio of nuclear-tocytoplasmic staining (Figures 4A and 4B) . In Figures 4A and 4B, NFATc1, TH, or DAPI images are displayed in red, green, or blue, respectively, so in the merged DAPI+NFATc1 images, purple regions indicate greater NFATc1 localization to the nuclei. Consistent with the transfected EGFP-NFAT data, both types of stimulation increased endogenous NFATc1 nuclear staining within 15 min, and the augmented level of nuclear NFATc1 persisted for at least 120 min ( Figures 4C and 4D ). In sum, we demonstrate that stimulation of rat sympathetic neurons by either 50 K + or ACh elicits translocation of both exogenous EGFP-tagged NFATc1 and NFATc2 and endogenous NFATc1 from the cytoplasm to the nucleus, concurrent with increases in [Ca 2+ ] i .
Inhibition of CaN/NFAT Signaling Pathways Abolishes Activity-Dependent Upregulation of M-Channel Expression
To further confirm the involvement of CaN-activated NFAT in the regulation of M-channel expression, endogenous NFAT signaling was inhibited pharmacologically by either the CaN inhibitor, cyclosporine A (CsA), or a stearated (St), membrane-permeable peptide, consisting of MAGPHPVIVITGPHEE (St-VIVIT), that inhibits the CaN/NFAT signaling pathway by competitively blocking the binding of CaN to NFAT, preventing NFAT dephosphorylation (Aramburu et al., 1999) . Cultured rat SCG neurons were pretreated with CsA or the St-VIVIT peptide for 1 hr before stimulation. The neurons were then (1) fixed and immunostained by antibodies against NFATc1 before stimulation by 50 K + , or at 15-120 min after stimulation, and imaged under confocal microscopy ( Figure 5A ); or (2) loaded with fura-2, stimulated by 50 K + for 10-15 min and simultaneous [Ca 2+ ] i and EGFP-NFATc1 imaging performed as before (Figure 5B) . In both experiments, we found that translocation of NFATc1 induced by 50 K + stimulation was blocked by CsA or the St-VIVIT peptide.
Perforated-patch experiments then tested the effect of blocking CaN/NFAT signaling on I M amplitudes. Neurons were pretreated with CsA, or the St-VIVIT peptide, 1 hr before and throughout the 50 K + stimulation, and studied after 48-60 hr.
Consistent with previous results, for the control neurons, we observed significantly augmented I M amplitudes after 50 K + stimulation (1.90 ± 0.18 pA/pF, n = 18; p < 0.001), compared with neurons treated with regular Ringer's solution (0.95 ± 0.09 pA/pF, n = 10) ( Figure 5C ). Pretreatment with CsA or the St-VIVIT peptide did not affect I M amplitudes in neurons treated with regular Ringer's solution (0.93 ± 0.16 pA/pF, n = 11, and 0.93 ± 0.12 pA/pF, n = 10, respectively), but both abolished the effect of augmented I M amplitudes induced by 50 K + stimulation (0.97 ± 0.08 pA/pF. n = 17, p < 0.001, and 0.87 ± 0.11 pA/ pF, n = 10, p < 0.001, respectively) ( Figures 5C and 5D ).
KCNQ2 and KCNQ3 Genes Are Regulated by NFAT
To prove that NFAT-mediated transcriptional regulation is causative of stimulation-induced increases in M-channel expression and I M upregulation, we sought to localize the site(s) of NFATc1 and NFATc2 on KCNQ2 and KCNQ3-channel promoter/ enhancer regions. Thus, we developed luciferase (firefly)-reporter assays using various promoter/enhancer domains, constructed by PCR from KCNQ2 and KCNQ3 genomic DNA. Instead of transfecting the reporter constructs in SCG neurons, which has a very low efficiency, we used the PC12 sympathetic neuronlike cells, which express M channels (Villarroel, 1996) and NFATs (Cano et al., 2005) that are activated by CaN dephosphorylation (Canellada et al., 2006) . We first performed a bioinformatic analysis of the promoter and first-intron regions of rat KCNQ2 and KCNQ3 genes to look for potential NFAT-binding domains, using the program MatInspect (version 3.3) (http://www.genomatix.de/cgi-bin/./eldorado/ main.pl), and found three such domains in KCNQ2 and one in KCNQ3, containing five total potential NFAT-binding sites with the core motif GGAAA or TTTCC. Thus, we made four luciferase-reporter constructs encompassing the corresponding putative NFAT-binding domains, with luciferase expression as the readout for NFAT activation and binding to the reporter constructs ( Figure 6A ).
PC12 cells were transfected with the four luciferase-reporter constructs encompassing the corresponding putative NFATbinding domains, and a constitutively active Renilla reniformis luciferase construct. One day later, the cells were stimulated as before by regular Ringer's, high K + , or ACh for 15 min, with termination by returning the cells to the culture medium. Cells were lysed after 2 days, and the resulting luciferase luminescence was measured. Figure 6B shows the results from KCNQ2 reporter constructs Q2RC1-Q2RC3 and the KCNQ3 reporter construct, Q3RC1. Significant firefly luciferase luminescence, normalized to the Renilla luciferase control, was observed 3 days after transfection for constructs Q2RC1-Q2RC3 and Q3RC1. Moreover, the luminescence increased at least 2-fold (p < 0.001) for constructs Q2RC1, Q2RC2, and Q3RC1, but not for construct Q2RC3, following stimulation of the cells by high K + or by ACh (n = 5). There was a negligible response from cells transfected with empty vector for any stimulation. Our luciferase data predict regions Q2RC1 and Q2RC2 of the KCNQ2 gene and Q3RC1 of the KCNQ3 gene to be critical for transcriptional upregulation. Finally, exposure of cells to CsA for 1 hr before stimulation by high K + or ACh did not alter the basal firefly luciferase luminescence for any of the reporter constructs; however, the increased luciferase luminescence induced by high K + or ACh was abrogated (n = 5) ( Figure 6C ), suggesting that the reporter signals are due to CaN/NFAT. -and activity-dependent reporter that drives NFATc4 activation in the hippocampus (Oliveria et al., 2007 both WT and KO mice (n = 14 and 20, respectively) but NFAT nuclear translocation only for neurons from WT mice ( Figures 7A and 7B ). Such data are summarized in Figures 7C and 7D (for statistics, see Supplemental Information). Thus, the absence of AKAP150 abolishes NFATc1 nuclear translocation induced by 50 K + stimulation. We then compared I M levels between neurons isolated from AKAP150 +/+ and AKAP150 À/À mice by patch-clamp electrophysiology. As before, mouse SCG neurons were treated with regular Ringer's or 50 K + solutions, and I M amplitudes were evaluated after 48-60 hr. There was no statistical difference in I M amplitudes from the two groups of neurons when treated with Ringer's solution (0.87 ± 0.05, n = 18, and 0.83 ± 0.09, n = 20), suggesting that the lack of AKAP150 does not affect basal expression levels of M channels. However, the effect of augmented I M amplitudes after 50 K + treatment (1.28 ± 0.08 pA/pF, n = 38; p < 0.01) was wholly absent in neurons from AKAP150 À/À mice (0.81 ± 0.08 pA/pF, n = 28) ( Figures 8A and 8B ).
Transfection of AKAP79 in AKAP150 -/-Neurons ''Rescues'' the Activity-Dependent Transcriptional Upregulation of M Channels To test whether the aforementioned result in AKAP150 KO neurons is truly due to the lack of AKAP150, such neurons were transfected with WT AKAP79, AKAP79 with a PKC-binding domain deletion (DA-AKAP79) (Klauck et al., 1996; Zhang et al., 2011) , or AKAP79 with a CaN-binding domain deletion (AKAP79DCaN) (Klauck et al., 1996; Oliveria et al., 2007) Figure 8C ). Within the CaN-binding site on AKAP79/150 is the sequence, PIAIIIT, satisfying the consensus CaN-binding sequence PIXIXIT, and its deletion prevents the CaN-AKAP79/150 interaction (Oliveria et al., 2007) . This deletion mutant (AKAP79DPIX) also failed to rescue the responses of augmented I M amplitudes after 50 K + stimulation in AKAP150 KO neurons (n = 9) (Figures 8C and 8D; (Cruzblanca et al., 1998; Gamper and Shapiro, 2003; Zaika et al., 2007) elevation, but EGFP-NFATc1 nuclear translocation was not observed (n = 22; Supplemental Information; Figure S1A ). For neurons stimulated in Ca
2+
-free external solution, we observed neither a [Ca 2+ ] i elevation nor EGFP-NFATc1 translocation (n = 12; Figure 9A ). We next used 50 K + (or ACh) solution added with (1) the L-type Ca 2+ -channel (L-channel) blocker nifedipine (10 mM), (2) the N-type Ca 2+ -channel (N-channel) blocker, u-conotoxin GVIA (Boland et al., 1994 ) (u-CgTX, 1 mM), or (3) the P/Qtype Ca 2+ -channel blocker, u-agatoxin-TK (Adams et al., 1993) (u-Aga-TK, 400 nM) on WT neurons to study which Ca 2+ channels are critical for CaN/NFAT signaling. We found u-Aga-TK to affect neither Ca 2+ responses nor EGFP-NFATc1 nuclear translocation (n = 14; Figure 9D ). With nifedipine added to the 50 K + or ACh solution, the [Ca 2+ ] i elevation was undiminished, but we did not observe EGFP-NFATc1 nuclear translocation ( Figure 9B , n = 19, and Figure S1B , n = 8). When u-CgTX was added to the 50 K + solution, both the [Ca 2+ ] i elevations and the EGFP-NFATc1 nuclear translocation were also diminished (n = 19; Figure 9C ). Such data are summarized in Figures 9G ] i elevations, most easily through N channels. We did two experiments to test these hypotheses. First, nuclear translocation of EGFPNFATc1 was tested on WT neurons loaded with either the slow Ca 2+ chelator, EGTA, or the fast Ca 2+ chelator, BAPTA, both loaded in the cell as the cell-permeant AM-ester ( Figure 9F ). EGFP-NFATc1 nuclear translocation induced by high-K + stimulation was dramatically suppressed by BAPTA (n = 23), consistent with our hypothesis that the initiation of NFAT signals depends on local [Ca 2+ ] i rises. However, EGTA yielded highly divergent results among cells, which we suspected was due to variable loading of EGTA-AM. Fura-2 imaging from these cells confirmed this ( Figure S1F ), and these cells were then further analyzed into two groups. The ''NS'' (nonsignificant) group of cells had no statistical increase of [Ca 2+ ] i (D 340/380 < 0.05, n = 9) and no NFATc1 nuclear translocation, whereas the ''S'' group were those with significant [Ca Figures 10A and 10B ). qPCR was also performed from WT SCG neurons 7 hr after perfusion of regular Ringer's, 50 K + , 50 K + with CsA, or 50 K + with nifedipine solutions for 15 min. We detected significant increases in the amount of both KCNQ2 and KCNQ3 mRNA in neurons depolarized by 50 K + (3.2 ± 0.8 and 3.9 ± 0.7, n = 4; p < 0.01). This elevated expression of KCNQ2 and KCNQ3 mRNA was suppressed when CsA (1.05 ± 0.20 and 1.41 ± 0.15, n = 4) or nifedipine (1.25 ± 0.28 and 1.61 ± 0.50, n = 4) was present during the stimulation (Figure 10C) . Thus, removal of external Ca 2+ , blockade of CaN, or addition of nifedipine during stimulation eliminates NFATc1 nuclear translocation and augmented KCNQ2/3 mRNA and I M amplitudes, suggesting the critical role of CaN and L-type channels for transcriptional regulation of M channels.
Seizures Induce Dramatic Augmentation of KCNQ2 and KCNQ3 Transcription, Requiring AKAP79/150 Our discovery that M-channel transcription is regulated by neuronal activity through NFAT/CaN signaling in sympathetic neurons led us to think that this may generalize throughout the nervous system to limit neuronal hyperexcitability. Thus, we measured the relative expression level of KCNQ2 and KCNQ3 transcripts in a pathological animal model of neuronal hyperexcitability, chemoconvulsant-induced seizures in mice. As the part of the brain often serving as the focal point for dangerous human seizures, we focused on the hippocampus. We used the pilocarpine as well as kainic acid (KA) convulsant-seizure models of inducing status epilepticus (Leite et al., 2002) , which corrects for any confound of altered M currents from muscarinic agonist (pilocarpine), rather than from hyperactivity. Visual scoring of seizure behavior was performed on each mouse (0, no phenotype; 1, vacant stare; 2, tremors and ''sticky'' feet; 3, flag pole tail; 4, full clonus), and only mice obtaining a score of three or four within 60 min after drug administration were used. We did not notice significantly different seizure stages in WT and AKAP150 À/À mice as previously reported by Tunquist et al. (2008) , except in response to the first dose of KA ( Figure S2 ). Hippocampi were isolated from mice 16-20 hr after intrapleural administration of either pilocarpine or KA, or only vehicle as a control, total RNA was extracted, and qPCR was performed. Indeed, a profound augmentation of both KCNQ2 and KCNQ3 mRNA was observed in mice after seizures induced by pilocarpine (27.9 ± 6.7-fold and 9.3 ± 2.2-fold, n = 18) or KA (8.7 ± 2.3-fold and 3.1 ± 0.6-fold, n = 25), compared with control mice injected with vehicle (1.1 ± 0.05-fold and 1.1 ± 0.10-fold, n = 17) ( Figures 10D and 10E ). This profoundly increased mRNA of both KCNQ2 and KCNQ3 in hippocampi from mice subjected to seizures is much greater than that seen from 50 K + or ACh treatment in cultured sympathetic neurons, suggesting that seizures induce exaggeration of this transcriptional regulation and could be conserved throughout the nervous system as a protective mechanism against hyperexcitability disorders such as epilepsy. Our mechanism predicts that this profound increase induced by seizures should likewise be dependent on AKAP150. Indeed, in AKAP150 À/À mice, there was almost no upregulation of KCNQ2 and KCNQ3 mRNA after pilocarpine-induced (1.5 ± 0.1 and 1.4 ± 0.1, n = 14) or KA-induced (1.8 ± 0.4 and 1.6 ± 0.2, n = 18) seizures ( Figures 10D and 10E ), confirming the central role of AKAP150 in this phenomenon. i /CaN signals, both NFATc1 and NFATc2 are dephosphorylated and translocate from the cytoplasm to the nucleus, where they act on KCNQ2 and KCNQ3 gene regulatory elements, upregulating I M , thus reducing excitability ( Figure 10F ). In a variety of neurons, AKAP79/150 orchestrates PKA to phosphorylate and upregulate the activity of L-type Ca 2+ channels, amplifying the responses to depolarization induced by neuronal activity. In the hippocampus, CaN counterbalances PKA actions since the Ca 2+ ions that enter the cell through L channels participate in inactivating those same channels via CaN Oliveria et al., 2007) . We show that in the same protein complex in which PKA augments L currents, AKAP79/150 directs CaN to activate NFAT and initiate a longer-term feedback loop that upregulates M-channel expression, thus countering increased neuronal excitability. This seeming dual competing action of AKAP79/150 is unexpected and intriguing. Recent structural and biochemical studies have revealed the stoichiometry of the core AKAP79 complex as a dimer with two CaN heterodimers, a PKA homodimer, with PKA binding to each AKAP79 protomer (Gold et al., 2011) . Thus, there lies the tempting possibility that AKAP79/150 not only brings PKA, PKC, and CaN to both L-type Ca 2+ channels and M-type K + channels, but it also physically couples one channel to the other in the same macromolecular complex, perhaps via the two protomers of the AKAP79/150 dimer (Gold et al., 2011) . Both channels are widespread with overlapped expression in the nervous system, with KCNQ2/3 clustered at the axon initial segments and nodes of Ranvier (Devaux et al., 2004; Klinger et al., 2011; Pan et al., 2006; Shah et al., 2008) , and L channels concentrated in the cell bodies and proximal dendrites of central neurons (Hell et al., 1993) . Recent findings in ventricular myocytes might shed some light on the role of AKAP79/150 in physical coupling between ion channels. Ca V 1.2 channels in those cells physically interact with each other at their carboxyl tails by AKAP79/150, resulting in the amplification of Ca 2+ influx and excitation-contraction coupling (Dixon et al., 2012) . Thus, the interaction between L channels and M channels could serve to fine-tune the activity of various neural circuits in an activitydependent manner. Why should L channels, which underlie no more than 15% of I Ca in rodent SCG neurons, be so critical for NFAT activation? Our hypothesis is that opening of specifically Ca V 1.3, as the dominant L channel in SCG (Lin et al., 1996) , creates an elevated local Ca 2+ i signal that is sensed by CaM and CaN recruited by AKAP79/150 to the microdomain of Ca V 1.3 channels. Although we did not rigorously test for physical association of AKAP79/150 with Ca V 1.3 channels using FRET or coIP as was done in the hippocampus for Ca V 1.2 (Oliveria et al., 2007) , we strongly predict that such intimate association must be the case also in sympathetic ganglia. Interestingly, blockade of the N channels that dominate I Ca in sympathetic neurons also abolished NFATc1 nuclear translocation, in addition to most of the 50 K + or ACh-induced [Ca 2+ ] i rises. Another lab investigating NFAT translocation in the same SCG cells has suggested that influx through N, not L, channels to be the driving force for NFAT activation by electrical stimulation (Herná ndez-Ochoa et al., 2007) , a result that might be compatible with the dual requirement found here. If L channels play a central role in CaN/NFAT activation by clustering the Ca V 1.3/CaM/CaN complex through AKAP79/150, why then is there a requirement for N channels? CaN is thought to rapidly dissociate from the AKAP79 complex to interact with NFAT (Li et al., 2012) . Dephosphorylated NFAT then translocates from cytoplasm to nucleus, which requires at least 5-10 min. During this period, NFAT must remain dephosphorylated and CaN activated. CaN is believed to remain bound to NFAT to keep it dephosphorylated during its import into the nucleus. What keeps CaN activated even when it translocates away from the ''local'' elevated [Ca 2+ ] needed to occupy the low-affinity sites on apoCaN and cause modest activation is around 1 mM, with V max increased more than 20-fold in the presence of Ca 2+ /CaM (Feng and Stemmer, 2001; Klee et al., 1998 expected from stimulating SCG cells (Gamper and Shapiro, 2003) . Clearly, our hypothesis needs to be confirmed by biochemical studies of the Ca 2+ /CaM affinity of CaN when it is bound to AKAP79/150, or to NFAT. We find translocation of NFATc1/c2 to lag well behind the induced Ca 2+ i rises, similar to that seen in BHK cells or Jurkat lymphocytes, in which NFAT was shown to be rapidly dephosphorylated by CaN, but NFAT nuclear import to be >10-fold slower. This phenomenon has been described as providing for a ''working memory of Ca 2+ i signals'' (Kar et al., 2012; Tomida et al., 2003) , but the mechanism responsible for this temporal discrepancy is, as yet, unclear.
DISCUSSION
Our ] i rise that we suggest maintains NFAT active during its transit into the nucleus. As to the induction of NFAT translocation by TRPV activation in DRG neurons, we suggest that mechanism to be akin to the NFAT translocation induced by AChR stimulation seen here in SCG cells. For the latter, our model supposes the AChRs to cause NFAT translocation not from Ca 2+ influx through the AChRs themselves but from robust depolarization, which opens L channels, beginning the CaN/ NFAT cascade. We suggest that the TRPV mechanism on NFAT in sensory neurons could be similar, especially since Kim and Usachev (2009) did not block L channels during their capsaicin stimulations. Finally, the NFAT isoform shown to translocate in an L-channel-dependent manner in hippocampal neurons is NFATc4 (Oliveria et al., 2007) , whereas we found translocation only for NFATc1 and NFATc2, but not NFATc3 and NFATc4. Probably, distinct NFAT subtypes are activated in distinct neuronal types.
M Current as an ''Antiepileptogenic'' versus ''Anticonvulsant'' Target Identified from patients with inherited neonatal syndrome, benign familial neonatal convulsions (BFNCs), M channels formed by KCNQ2/3 heteromers have proven a promising therapeutic antiepileptic target. Although more than 20 antiepileptic drugs, including the M-channel opener, retigabine, are available on the market, one-third of patients cannot control their epilepsy satisfactorily due to various reasons, one of which is the fact of these drugs being only seizure suppressing, or ''anticonvulsant,'' but not seizure preventing, or ''antiepileptogenic'' (Stafstrom et al., 2011) . Transcription of KCNQ2/3 genes has been suggested to be developmentally regulated (Hadley et al., 2003; Tinel et al., 1998) , which may underlie the remission of BFNCs seen in the clinic. Here, we show that transcription of KCNQ2 and KCNQ3 subunits is upregulated by stimulation, with massive upregulation in hippocampi after seizures. Thus, as an important ''antiepileptic'' target to suppress seizures, M channels may also be as critical a pharmacological ''antiepileptogenic'' target to prevent recurrent seizures, i.e., epilepsy. Another lab showed AKAP150 À/À mice to be resistant to chemically induced seizure onset (Tunquist et al., 2008) , although our findings in that regard are much more subtle. Indeed, we find that the profound upregulation of KCNQ2 and KCNQ3 transcription levels after such seizures is nearly abrogated in hippocampi isolated from AKAP150 À/À mice, suggesting that these mice would be much more vulnerable to epileptogenesis after seizures. This prediction will be very interesting to test, although other factors involved in enhanced seizure susceptibility, such as decreased GABA A expression, changes in HCN-channel expression, or activation of inflammatory responses (Rakhade and Jensen, 2009) , must be controlled for. Interestingly, strong upregulation of CaN and BDNF mRNA and protein levels has been reported after hypoxia-, pilocarpine-, or KA-induced seizures (Rakhade and Jensen, 2009 ), suggesting another mechanism by which seizures should increase CaN-dependent transcriptional actions.
The events cocoordinated by AKAP proteins range spatially from the membrane to the nucleus, and temporally over many orders of magnitude, from the second to the lifetime of the organism. These signaling complexes could play important roles to limit epileptic seizures and to restrict undue longterm, highly plastic phenomena, such as limiting unnecessary formation of dendritic connections and superfluous, or redundant, circuits in the brain. Both KCNQ2 transgenic dominantnegative mice and AKAP150 mutant or KO mice display impaired hippocampus-dependent learning and memory, with the latter exhibiting deficits in strength and motor coordination as well (Peters et al., 2005; Tunquist et al., 2008; Weisenhaus et al., 2010) . Additionally, malfunction of AKAP79/150-NFAT signaling may underlie exaggerations of cerebral mood and disease syndromes of the peripheral nervous system, such as chronic pains and cardiovascular dysfunction. À/À mice has been described (Zhang et al., 2011) .
Perforated-Patch Electrophysiology
M currents in SCG cells were studied by holding the membrane potential at À25 mV and applying a 500 ms hyperpolarizing pulse to À60mV every 5 s. I M amplitude was measured at À60 mV from the decaying time course of the deactivating current sensitive to the M-channel-specific blocker XE991 (Zaczek et al., 1998) . Further details are in Supplemental Experimental Procedures.
Quantitative Real-Time PCR (qPCR) SCG neurons were prepared using the protocol described in Supplemental Experimental Procedures. Cytosine arabinoside (Ara-c, 5 mM) as a mitotic inhibitor was added in the medium to prevent astrocyte growth. On day 2 in vitro, neurons were stimulated by application of 50 mM K + or ACh (1 mM) for 15 min. Stimulation was terminated by returning the neurons in culture medium. Experiments were repeated at least three times using RNA collected from at least three separate SCG cultures, and each culture was prepared from >15 rats or mice.
Dual-Luciferase-Based Gene Reporter Assays PC12 cells were cotransfected with plasmids encoding a luciferase (firefly)-based reporter and a constitutively active Renilla reniformis luciferase under the control of a thymidine kinase promoter (pRL-TK; Promega, Madison, WI, USA) by the Lipofectamine 2000 reagent (Invitrogen; 11668-019). Twenty-four hours later, the cells were stimulated by application of high K + or ACh (1 mM) for 15 min. In experiments with inhibitors, the cells were exposed to the inhibitors (CsA, st-VIVIT) for 1 hr and then treated with high-K + stimulation in solutions containing the inhibitors. Two days after stimulation, cells were lysed, the activity of each luciferase construct was measured sequentially on a TD-20/ 20 luminometer (Turner Biosystem, Sunnyvale, CA, USA), and data were calculated according to the instructions of the Dual-Luciferase Reporter Assay System kit (Promega). Each experiment was conducted as least three times.
Simultaneous Imaging of [Ca
2+
] i and GFP-Labeled NFAT Isoforms Rat or mice SCG neurons transfected with EGFP-NFATc1-NFATc4 were bath loaded with the Ca 2+ -sensitive indicator fura-2 (fura-2 AM, 2 mm) for 30 min at 37 C in the presence of pluronic acid (0.01%). [Ca 2+ ] i elevation and nuclear import of NFAT isoforms were induced by high-K + -induced depolarization or nicotinic ACh receptor agonist ACh (1 mM). Cells were placed in a flowthrough chamber mounted on the stage of an inverted Nikon Eclipse TE300 microscope, perfused with standard Ringer's solution. Fluorescence was excited alternatively at 340, 380, and 470 nm (50-200 ms every 15 s) using a Polychrome IV monochromator (TILL Photonics, Martinsreid, Germany) through a FURA2/GFP filter cube. Data were processed using TILLvisION 4.0 and ImageJ software and presented as mean ± SEM.
Pilocarpine and Kainic Acid (KA) Administration One-month-old male mice (C57BL/6) were given subcutaneous injections of (1) methyl scopolamine nitrate (1 mg/kg, in sterile saline) to reduce peripheral cholinergic agonist-induced side effects, and 30 min later pilocarpine (280 mg/ kg, in saline); (2) KA (10 mg/kg, in saline) every hour for three times; or (3) saline as negative control. Mice were closely observed during and 1 hr after pilocarpine or KA injections, and their seizure behaviors were assigned a rating for each 15 min period according to a seizure-staging system adapted from established (Racine, 1972 ) rodent seizure scales (Winawer et al., 2007) .
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